Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
Biden to propose overhaul of U.S. nursing homes
Mar 01, 2022
Plan will include 20 separate actions to improve nursing home quality
Rural, urban disparities seen for quality of home healthcare
Jan 13, 2022
Rural home health care agencies perform better on process measures; urban agencies perform better on outcome measures.
Medicare to cover Wegovy when patients also have heart disease
Mar 22, 2024
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
U.S. national healthcare spending increased 9.7 percent in 2020
Dec 17, 2021
The increase was due to 36% increase in federal expenditures, mainly in response to the COVID-19 pandemic.
Biogen is dropping controversial Alzheimer’s drug Aduhelm
Jan 31, 2024
Biogen said it will shift its focus to a newer Alzheimer’s drug, Leqembi, which it markets in a partnership with Japan-based Eisai. Leqembi received FDA approval last year.
Medicare mulls coverage for controversial drug for Alzheimer’s disease
Jul 13, 2021
CMS says a final decision on coverage is not likely until next spring.
Medicare will cover new class of Alzheimer’s drugs if fully approved by FDA, with limits
Jun 02, 2023
Drug makers also will have to gather and keep data in a registry showing how the drugs are working in the real world.
Medicare monthly premiums to drop for seniors
Sep 28, 2022
The fee cuts come at the same time as seniors receive a Social Security cost-of-living increase for 2023 of up to 9 or 10%.
Race/ethnicity-linked differences seen in type 1 diabetes management
Dec 23, 2021
Insulin pump use higher among white versus Black and other Medicare beneficiaries.